Literature DB >> 18704423

Mathematical modelling of competitive LDL/VLDL binding and uptake by hepatocytes.

T Pearson1, J A D Wattis, B O'Malley, L Pickersgill, H Blackburn, K G Jackson, H M Byrne.   

Abstract

Elevated levels of low-density-lipoprotein cholesterol (LDL-C) in the plasma are a well-established risk factor for the development of coronary heart disease. Plasma LDL-C levels are in part determined by the rate at which LDL particles are removed from the bloodstream by hepatic uptake. The uptake of LDL by mammalian liver cells occurs mainly via receptor-mediated endocytosis, a process which entails the binding of these particles to specific receptors in specialised areas of the cell surface, the subsequent internalization of the receptor-lipoprotein complex, and ultimately the degradation and release of the ingested lipoproteins' constituent parts. We formulate a mathematical model to study the binding and internalization (endocytosis) of LDL and VLDL particles by hepatocytes in culture. The system of ordinary differential equations, which includes a cholesterol-dependent pit production term representing feedback regulation of surface receptors in response to intracellular cholesterol levels, is analysed using numerical simulations and steady-state analysis. Our numerical results show good agreement with in vitro experimental data describing LDL uptake by cultured hepatocytes following delivery of a single bolus of lipoprotein. Our model is adapted in order to reflect the in vivo situation, in which lipoproteins are continuously delivered to the hepatocyte. In this case, our model suggests that the competition between the LDL and VLDL particles for binding to the pits on the cell surface affects the intracellular cholesterol concentration. In particular, we predict that when there is continuous delivery of low levels of lipoproteins to the cell surface, more VLDL than LDL occupies the pit, since VLDL are better competitors for receptor binding. VLDL have a cholesterol content comparable to LDL particles; however, due to the larger size of VLDL, one pit-bound VLDL particle blocks binding of several LDLs, and there is a resultant drop in the intracellular cholesterol level. When there is continuous delivery of lipoprotein at high levels to the hepatocytes, VLDL particles still out-compete LDL particles for receptor binding, and consequently more VLDL than LDL particles occupy the pit. Although the maximum intracellular cholesterol level is similar for high and low levels of lipoprotein delivery, the maximum is reached more rapidly when the lipoprotein delivery rates are high. The implications of these results for the design of in vitro experiments is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704423      PMCID: PMC2798995          DOI: 10.1007/s00285-008-0205-z

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  13 in total

1.  Characterization of the low density lipoprotein receptor in membranes prepared from human fibroblasts.

Authors:  S K Basu; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

2.  Saturated fat-induced changes in Sf 60-400 particle composition reduces uptake of LDL by HepG2 cells.

Authors:  Kim G Jackson; Vatsala Maitin; David S Leake; Parveen Yaqoob; Christine M Williams
Journal:  J Lipid Res       Date:  2005-11-08       Impact factor: 5.922

3.  Kinetics of low-density lipoprotein receptor activity in Hep-G2 cells: derivation and validation of a Briggs-Haldane-based kinetic model for evaluating receptor-mediated endocytotic processes in which receptors recycle.

Authors:  H J Harwood; L D Pellarin
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

Review 4.  Receptor-mediated endocytosis: insights from the lipoprotein receptor system.

Authors:  M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

5.  Coated pits, coated vesicles, and receptor-mediated endocytosis.

Authors:  J L Goldstein; R G Anderson; M S Brown
Journal:  Nature       Date:  1979-06-21       Impact factor: 49.962

6.  Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.

Authors:  Dick C Chan; Gerald F Watts; Trevor G Redgrave; Trevor A Mori; P Hugh R Barrett
Journal:  Metabolism       Date:  2002-08       Impact factor: 8.694

7.  Cellular free cholesterol in Hep G2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity.

Authors:  L M Havekes; E C de Wit; H M Princen
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

8.  Mathematical model for low density lipoprotein (LDL) endocytosis by hepatocytes.

Authors:  J A D Wattis; B O'Malley; H Blackburn; L Pickersgill; J Panovska; H M Byrne; K G Jackson
Journal:  Bull Math Biol       Date:  2008-08-21       Impact factor: 1.758

9.  Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse.

Authors:  Y Osono; L A Woollett; J Herz; J M Dietschy
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Iterative fractionation of recycling receptors from lysosomally destined ligands in an early sorting endosome.

Authors:  K W Dunn; T E McGraw; F R Maxfield
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  2 in total

1.  Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease.

Authors:  Magda O Seixas; Larissa C Rocha; Mauricio B Carvalho; Joelma F Menezes; Isa M Lyra; Valma M L Nascimento; Ricardo D Couto; Ájax M Atta; Mitermayer G Reis; Marilda S Goncalves
Journal:  Lipids Health Dis       Date:  2010-08-27       Impact factor: 3.876

Review 2.  Nutritional systems biology modeling: from molecular mechanisms to physiology.

Authors:  Albert A de Graaf; Andreas P Freidig; Baukje De Roos; Neema Jamshidi; Matthias Heinemann; Johan A C Rullmann; Kevin D Hall; Martin Adiels; Ben van Ommen
Journal:  PLoS Comput Biol       Date:  2009-11-26       Impact factor: 4.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.